Strand Diagnostics appointed Laura Beggrow as its president. The company recruited Beggrow to lead sales and marketing efforts.
Prior to joining Strand, Beggrow was VP of US sales and marketing at Genomic Health, where she helped grow annual sales of the Oncotype DX test from $10 million to more than $200 million.